Terms: = Gastric cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864
89 results:
1. [Preliminary Investigation of the Molecular Mechanism of Empagliflozin Suppressing gastric cancer Through Mammalian Target of Rapamycin].
Rao H; Cheng W; Yu J; An X; Deng H; Zhang Z; Wu F; Ji F; Li S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1146-1153. PubMed ID: 38162062
[TBL] [Abstract] [Full Text] [Related]
2. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
3. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
4. Subcellular localization of nucleolar protein 14 and its proliferative function mediated by miR-17-5p and E2F4 in pancreatic cancer.
Du YX; Zhou Y; Zheng XH; Duan YJ; Gu ZT; Yin YF; Wang CF
Aging (Albany NY); 2023 Jul; 15(14):7308-7323. PubMed ID: 37506248
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma.
Liang C; Liang Y; Ou B; Yuan L; Yuan S
Saudi J Gastroenterol; 2023; 29(4):240-250. PubMed ID: 37470667
[TBL] [Abstract] [Full Text] [Related]
6. Unique Genomic Alterations and Microbial Profiles Identified in Patients With gastric cancer of African, European, and Asian Ancestry: A Novel Path for Precision Oncology.
Abate M; Walch H; Arora K; Vanderbilt CM; Fei T; Drebin H; Shimada S; Maio A; Kemel Y; Stadler ZK; Schmeltz J; Sihag S; Ku GY; Gu P; Tang L; Vardhana S; Berger MF; Brennan MF; Schultz ND; Strong VE
Ann Surg; 2023 Oct; 278(4):506-518. PubMed ID: 37436885
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic structural aberration landscape in gastric cancer genomes.
Saito-Adachi M; Hama N; Totoki Y; Nakamura H; Arai Y; Hosoda F; Rokutan H; Yachida S; Kato M; Fukagawa A; Shibata T
Nat Commun; 2023 Jun; 14(1):3688. PubMed ID: 37349325
[TBL] [Abstract] [Full Text] [Related]
8. Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial.
Hu Q; Oki E; Yamada T; Kashiwada T; Sonoda H; Kataoka M; Kawanaka H; Tsuji Y; Makiyama A; Nakashima Y; Ota M; Kimura Y; Yoshizumi T
Cancer Med; 2023 Aug; 12(15):16649-16660. PubMed ID: 37325934
[TBL] [Abstract] [Full Text] [Related]
9. Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing cancers.
DiPeri TP; Evans KW; Raso MG; Zhao M; Rizvi YQ; Zheng X; Wang B; Kirby BP; Kong K; Kahle M; Yap TA; Dumbrava EE; Ajani JA; Fu S; Keyomarsi K; Meric-Bernstam F
Clin Cancer Res; 2023 Nov; 29(21):4385-4398. PubMed ID: 37279095
[TBL] [Abstract] [Full Text] [Related]
10. Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer.
Chen X; Bai K; Zhang Y; Xu Y; Huo Y; Wang S; Zou Y; Qi X; Guo R; Ou Q; Liu D; Yin S; Chen S; Bu H
J Transl Med; 2023 May; 21(1):296. PubMed ID: 37131253
[TBL] [Abstract] [Full Text] [Related]
11. Long-term oncologic and surgical outcomes of robotic and laparoscopic gastrectomy for Siewert II/III esophagogastric junction carcinoma: A propensity score-matched retrospective cohort study.
Lin X; Tan C; Li Z; Wu W; Cheng X; Qian F; Shi Y; Zhao Y
Eur J Surg Oncol; 2023 Sep; 49(9):106898. PubMed ID: 37019806
[TBL] [Abstract] [Full Text] [Related]
12. Two decades of gastric and gastroesophageal junction cancer surgery.
Plum PS; Pamuk A; Barutcu AG; Mallmann C; Niesen E; Berlth F; Zander T; Chon SH; Moenig SP; Quaas A; Bruns CJ; Hoelscher AH; Alakus H
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7679-7688. PubMed ID: 37000260
[TBL] [Abstract] [Full Text] [Related]
13. Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment.
Kwon HJ; Park Y; Nam SK; Kang E; Kim KK; Jeong I; Kwak Y; Yoon J; Kim TY; Lee KW; Oh DY; Im SA; Kong SH; Park DJ; Lee HJ; Kim HH; Yang HK; Lee HS
Cancer Med; 2023 May; 12(9):10371-10384. PubMed ID: 36916290
[TBL] [Abstract] [Full Text] [Related]
14. Examining the effect of
Ahmadzadeh A; Rashidi M; Mohsenifar Z; Faeghi F; Rezaei-Tavirani M; Ahmadi N; Zali MR; Alebouyeh M; Feizi M; Ahmadzadeh Z
Horm Mol Biol Clin Investig; 2023 Sep; 44(3):251-258. PubMed ID: 36872607
[TBL] [Abstract] [Full Text] [Related]
15. Lycopene suppresses gastric cancer cell growth without affecting normal gastric epithelial cells.
Zhou Y; Fu R; Yang M; Liu W; Tong Z
J Nutr Biochem; 2023 Jun; 116():109313. PubMed ID: 36871837
[TBL] [Abstract] [Full Text] [Related]
16. Chromosomally Unstable gastric cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism.
Dwivedi S; Hernández-Montes G; Montaño LF; Rendón-Huerta EP
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430456
[TBL] [Abstract] [Full Text] [Related]
17. Immunohistochemical and molecular analysis of an α-fetoprotein-producing cervical adenocarcinoma with clear cell morphology.
Kuriyama S; Yano M; Kusaba T; Zaitsu S; Nishida H; Yasuda M; Nasu K
Med Mol Morphol; 2023 Mar; 56(1):20-27. PubMed ID: 36183278
[TBL] [Abstract] [Full Text] [Related]
18. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
19. DEMoS: a deep learning-based ensemble approach for predicting the molecular subtypes of gastric adenocarcinomas from histopathological images.
Wang Y; Hu C; Kwok T; Bain CA; Xue X; Gasser RB; Webb GI; Boussioutas A; Shen X; Daly RJ; Song J
Bioinformatics; 2022 Sep; 38(17):4206-4213. PubMed ID: 35801909
[TBL] [Abstract] [Full Text] [Related]
20. Defining and Targeting Esophagogastric cancer Genomic Subsets With Patient-Derived Xenografts.
Moy RH; Walch HS; Mattar M; Chatila WK; Molena D; Strong VE; Tang LH; Maron SB; Coit DG; Jones DR; Hechtman JF; Solit DB; Schultz N; de Stanchina E; Janjigian YY
JCO Precis Oncol; 2022 Feb; 6():e2100242. PubMed ID: 35138918
[TBL] [Abstract] [Full Text] [Related]
[Next]
